# LEVOCARNITINE
> **ANDA217430** · Abbreviated New Drug Application (Generic) · Sponsor: DEVA HOLDING AS · Approved 2025-06-30
## Drug
- **FDA Application Number:** ANDA217430
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVOCARNITINE
- **Generic name:** LEVOCARNITINE
- **Active ingredients:** LEVOCARNITINE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** DEVA HOLDING AS
- **Manufacturer:** Devatis Inc.
- **First approval:** 2025-06-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217430)
---
*AI Analytics · CC0 1.0*